Evidence map›Paper›PMID 38242985›Full record

ArticleScientific reports2024

Predicting CKD progression using time-series clustering and light gradient boosting machines.

Hirotaka Saito, Hiroki Yoshimura, Kenichi Tanaka, Hiroshi Kimura, Kimio Watanabe, Masaharu Tsubokura, Hiroki Ejiri, Tianchen Zhao, Akihiko Ozaki, Sakumi Kazama and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hirotaka SaitoDepartment of Nephrology and Hypertension, Fukushima Medical University, 1 Hikariga-Oka, Fukushima City, Fukushima, 960-1295, Japan.
Hiroki YoshimuraDepartment of Radiation Health Management, Fukushima Medical University, Fukushima, Japan.
Kenichi TanakaDepartment of Nephrology and Hypertension, Fukushima Medical University, 1 Hikariga-Oka, Fukushima City, Fukushima, 960-1295, Japan. kennichi@fmu.ac.jp.
Hiroshi KimuraDepartment of Nephrology and Hypertension, Fukushima Medical University, 1 Hikariga-Oka, Fukushima City, Fukushima, 960-1295, Japan.
Kimio WatanabeDepartment of Nephrology and Hypertension, Fukushima Medical University, 1 Hikariga-Oka, Fukushima City, Fukushima, 960-1295, Japan.
Masaharu TsubokuraDepartment of Radiation Health Management, Fukushima Medical University, Fukushima, Japan.
Hiroki EjiriDepartment of Nephrology and Hypertension, Fukushima Medical University, 1 Hikariga-Oka, Fukushima City, Fukushima, 960-1295, Japan.
Tianchen ZhaoDepartment of Radiation Health Management, Fukushima Medical University, Fukushima, Japan.
Akihiko OzakiDepartment of Thyroid and Endocrinology, Fukushima Medical University, Fukushima, Japan.
Sakumi KazamaDivision of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan.
Michio ShimabukuroDivision of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan.
Koichi AsahiDivision of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan.
Tsuyoshi WatanabeDivision of Advanced Community Based Care for Lifestyle Related Diseases, Fukushima Medical University, Fukushima, Japan.
Junichiro J KazamaDepartment of Nephrology and Hypertension, Fukushima Medical University, 1 Hikariga-Oka, Fukushima City, Fukushima, 960-1295, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting the transition of kidney function in chronic kidney disease is difficult as specific symptoms are lacking and often overlooked, and progress occurs due to complicating factors. In this study, we applied time-series cluster analysis and a light gradient boosting machine to predict the trajectories of kidney function in non-dialysis dependent chronic kidney disease patients with baseline estimated glomerular filtration rate (GFR) ≥ 45 mL/min/1.73 m

Indexed as

Renal Insufficiency, ChronicAlgorithmsCluster AnalysisGlomerular Filtration RateHumansTime Factors

Identifiers

PMID38242985
PMCPMC10798962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.